• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      CRISPR Combined with Glowing Proteins for Viral Detection

      CRISPR Combined with Glowing Proteins for Viral Detection

      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

    • Radiology
      Imaging Technique Reveals Contraction Patterns During Labor

      Imaging Technique Reveals Contraction Patterns During Labor

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

      Antibacterial Smart Sutures Visible in CT Scans

      Antibacterial Smart Sutures Visible in CT Scans

    • Cardiology
      Scientists Grow Electrodes Inside The Body

      Scientists Grow Electrodes Inside The Body

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

    • Surgery
      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Self-Assembling Peptides as a Bioink

      Self-Assembling Peptides as a Bioink

    • Nanomedicine
      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Biliary Tract Cancer Market to Climb With the Active Participation of Key Companies Such as Incyte Corporation, Loxo Oncology, Bayer, Roche, Genentech, and Others, Assesses DelveInsight

March 9th, 2023 DelveInsight Business Research LLP Releases

DelveInsight’s “Biliary Tract Cancer – Market Insight, Epidemiology and Market Forecast – 2032” report provides current treatment practices, emerging drugs, Biliary Tract Cancer market share of the individual therapies, current and forecasted Biliary Tract Cancer market size from 2019 to 2032 segmented by seven major markets. The report also offers current Biliary Tract Cancer therapy algorithms, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Biliary Tract Cancer market.

Key Takeaways from the Biliary Tract Cancer Market Report

  • According to DelveInsight estimates, the total market size of Biliary Tract Cancer in the 7MM is approximately USD 553 million in 2021 and is projected to increase during the forecast period (2023-2032).
  • As per the assessment done by DelveInsight, the total incident cases of Biliary Tract Cancer in the 7MM comprised of approximately 37K cases in 2021 and are projected to increase during the forecasted period.
  • Leading Biliary Tract Cancer companies such as Incyte Corporation, Loxo Oncology, Bayer, Roche, Genentech, QED Therapeutics, Agios Pharmaceuticals, Servier Pharmaceuticals, Merck Sharp & Dohme, AstraZeneca, Taiho Oncology, Delcath Systems, Eisai, TransThera Sciences (Nanjing), Basilea Pharmaceutica, Zymeworks, BeiGene, and others are developing novel Biliary Tract Cancer drugs that can be available in the Biliary Tract Cancer market in the upcoming years.
  • Promising Biliary Tract Cancer therapies in the pipeline include Keytruda (pembrolizumab), Imfinzi (durvalumab), Futibatinib (TAS-120), Melphalan, E7090 (tasurgratinib), TT-00420, ARQ 087 (Derazantinib), Lenvima (lenvatinib), Zanidatamab, and others.

Discover more about therapies set to grab major Biliary Tract Cancer market share @ Biliary Tract Cancer Market Report

Biliary Tract Cancer Overview

Hepatocellular carcinoma (HCC), biliary tract cancer (BTC), and other metastatic diseases are among the most common malignant hepatic lesions. Biliary tract cancer (BTC) is an epithelial malignancy of the biliary tree that includes the following: GBC and Cholangiocarcinoma (CCA). The symptoms of biliary tract cancer vary depending on the location of the tumor and can include pruritus, abdominal pain, malaise, fatigue, jaundice, pale stool or clay-colored stools, and dark urine, palpable gallbladder, painless jaundice, which is the presenting symptom in 90% of perihilar cholangiocarcinoma (pCCA), and others.

Most patients develop BTC without identifiable risk factors, as most cases are sporadic and lack identifiable risk factors. Patients with BTC typically undergo endoscopic retrograde cholangiopancreatography, as well as cytology, brushing, FISH (fluorescence in situ hybridization)-polisomy, biopsy, ultrasonography, choledochoscopy, cholangioscopy, chromoendoscopy, confocal endoscopy, and narrow-band imaging. MRI, CT, endoscopic ultrasonography or 18FDG PET-CT cannot definitively demonstrate the stricture’s neoplastic nature.

Learn more about the Biliary Tract Cancer treatment guidelines @ Biliary Tract Cancer Guidelines

Biliary Tract Cancer Epidemiological Insights

As per DelveInsight, the total incident cases of Biliary Tract Cancer in the 7MM was approx 37K in 2021.

As per the analysis, the most number of BTC cancer cases were found in Japan, followed by the US in 2021. 

The Biliary Tract Cancer market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total incident cases
  • Total age-specific cases
  • Total stage-specific cases
  • Total mutation-specific cases
  • Total treated cases

Download the report to understand which factors are driving Biliary Tract Cancer epidemiology trends @ Biliary Tract Cancer Epidemiological Insights

Biliary Tract Cancer Treatment Market 

Given the complexity of biliary tract cancer, clinical management should be planned as part of a multidisciplinary team that takes into account patient-related factors (eg, ECOG performance status, comorbidities, preferences), disease-related variables (eg, tumor stage, vascular involvement, presence of distant metastases), and availability of specialist expertise (high-volume centers have a lower mortality rate for major liver resections). The approach to surgery depends on the primary site of the disease and is the cornerstone of curative therapy. Surgery with complete resection is the only curative treatment option for CCA and GBC. In iCCA, affected segments or lobes are usually resected; in dCCA, pancreatoduodenectomy is performed. Depending on the extent of the tumor, resection may be done in the involved intrahepatic andsextrahepatic bile ducts, the associated ipsilateral liver, the gallbladder, and regional lymph nodes in pCCA as well as GBC.

To know more about Biliary Tract Cancer treatment options, visit @ Biliary Tract Cancer Drugs

Biliary Tract Cancer Pipeline Therapies 

  • Keytruda (pembrolizumab)
  • Imfinzi (durvalumab)
  • Futibatinib (TAS-120)
  • Melphalan
  • E7090 (tasurgratinib)
  • TT-00420
  • ARQ 087 (Derazantinib)
  • Lenvima (lenvatinib)
  • Zanidatamab

Biliary Tract Cancer Key Companies

  • Incyte Corporation
  • Loxo Oncology
  • Bayer
  • Roche
  • Genentech
  • QED Therapeutics
  • Agios Pharmaceuticals
  • Servier Pharmaceuticals
  • Merck Sharp & Dohme
  • AstraZeneca
  • Taiho Oncology
  • Delcath Systems
  • Eisai
  • TransThera Sciences (Nanjing)
  • Basilea Pharmaceutica
  • Zymeworks
  • BeiGene

Learn more about the Biliary Tract Cancer therapies in clinical trials @ New Treatment for Biliary Tract Cancer

Biliary Tract Cancer Market Dynamics

Clinical progress in targeting HER2 for GBC treatment has been disappointingly slow. First, the low prevalence of GBC, in general, makes it difficult to enroll patients in clinical trials with a large enough sample size. Given the limited benefits of available therapies and the anatomical, pathological, and molecular heterogeneity of BTC, there is an unmet and urgent need for comprehensive genomic profiling to improve understanding of the pathogenesis of BTC and to enable personalized treatment. There is an increasing need for approved therapies for this disease.

Moreover, there is a significant lack of education and awareness among patients and practitioners about this disease and its associated misdiagnosis. There is a lack of understanding about the disease’s diagnosis, treatment, and pathophysiology. Despite recent advances, diagnosing BTC at an early enough stage to qualify for curative treatment options remains a significant challenge. As a result, there is an urgent need to raise awareness about this disease, as different subtypes exist depending on the location of the biliary tract.

Scope of the Biliary Tract Cancer Market Report

    • Study Period: 2019–2032
    • Coverage: 7MM [The United States, EU4 (Germany, France, Italy, and Spain)], the United Kingdom), and Japan
    • Key Biliary Tract Cancer Companies: Incyte Corporation (NASDAQ: INCY), Loxo Oncology, Bayer (ETR: BAYN), Roche (SWX: ROG), Genentech, QED Therapeutics, Agios Pharmaceuticals (NASDAQ: AGIO), Servier Pharmaceuticals, Merck Sharp & Dohme (NYSE: MRK), AstraZeneca (LON: AZN), Taiho Oncology, Delcath Systems (NASDAQ: DCTH), Eisai, TransThera Sciences (Nanjing), Basilea Pharmaceutica (SWX: BSLN), Zymeworks (NASDAQ: ZYME), BeiGene, and others
    • Key Biliary Tract Cancer Therapies: Keytruda (pembrolizumab), Imfinzi (durvalumab), Futibatinib (TAS-120), Melphalan, E7090 (tasurgratinib), TT-00420, ARQ 087 (Derazantinib), Lenvima (lenvatinib), Zanidatamab, and others
    • Therapeutic Assessment: Biliary Tract Cancer current marketed and emerging therapies
    • Biliary Tract Cancer Market Dynamics:  Biliary Tract Cancer market drivers and barriers 
    • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
    • Unmet Needs, KOL’s views, Analyst’s views, Biliary Tract Cancer Market Access and Reimbursement

Discover more about Biliary Tract Cancer drugs in development @ Biliary Tract Cancer Clinical Trials

Table of Contents

1. Biliary Tract Cancer Market Key Insights
2. Biliary Tract Cancer Market Report Introduction
3. Biliary Tract Cancer Market Overview at a Glance
4. Biliary Tract Cancer Market Executive Summary
5. Disease Background and Overview
6. Biliary Tract Cancer Treatment and Management
7. Biliary Tract Cancer Epidemiology and Patient Population
8. Patient Journey
9. Biliary Tract Cancer Marketed Drugs
10. Biliary Tract Cancer Emerging Drugs
11. Seven Major Biliary Tract Cancer Market Analysis
12. Biliary Tract Cancer Market Outlook
13. Potential of Current and Emerging Therapies
14. KOL Views
15. Biliary Tract Cancer Market Drivers
16. Biliary Tract Cancer Market Barriers
17. Unmet Needs
18. SWOT Analysis
19. Appendix
20. DelveInsight Capabilities
21. Disclaimer
22. About DelveInsight

Related Reports

Biliary Tract Cancer Epidemiology

Biliary Tract Cancer Epidemiology Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted Biliary Tract Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Primary Biliary Cirrhosis Market

Primary Biliary Cirrhosis Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key primary biliary cirrhosis companies, including Cour Pharmaceutical Development, Ascletis, Novartis, Mirum Pharmaceuticals, Intercept Pharmaceuticals, among others.

Primary Sclerosing Cholangitis Market

Primary Sclerosing Cholangitis Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key primary sclerosing cholangitis companies,  including Mirum Pharmaceuticals, Chemomab Therapeutics, Cascade Pharmaceuticals, among others.

Primary Sclerosing Cholangitis Pipeline

Primary Sclerosing Cholangitis Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key primary sclerosing cholangitis companies,  including Mirum Pharmaceuticals, Chemomab Therapeutics, Cascade Pharmaceuticals, among others.

Other Trending Reports

Goitre Market | Thymus Cancer Market | US Healthcare Outlook Report | Venous Stenosis Market | Negative Pressure Wound Therapy Systems Market | Global Kinase Inhibitor in Autoimmune Diseases Market | Metrorrhagia Market | Dysfunctional Uterine Bleeding Market | Hypereosinophilic Syndrome Market | Age-related Vision Dysfunction Market | Dental Lasers Market | CRISPR Therapies Pipeline Insight | Cell And Gene Therapy For Multiple Myeloma Market | Drug Hypersensitivity Market | Dysthymia Market | Persistent Depressive Disorder Market | Cancer Vaccines Market | Global Messenger RNA (mRNA)-based Vaccines and Therapeutics Market |Spirometers Market | Hemodynamic Monitoring Systems Market | Deep Brain Stimulation Devices Market | Genital Herpes Market  | Guillain-Barre Syndrome (GBS) Market | Hot Flashes Market | Human Immunodeficiency Virus Type-1 (HIV-1) Market | Hypertrophic Scar Market | Sinus Dilation Devices Market | Artificial Cornea and Corneal Implant Market |Peripheral Neuritis Market | Peripheral Vascular Devices Market | Diphtheria Market | Glioma Market | Fallopian Tube Cancer Market | Implantable Cardioverter Defibrillators (ICDs) Market | Smart Inhalers Market | Thyroid Cancer Market | Hemostasis Market | Peptic Ulcers Market

Related Healthcare Services

Healthcare Business Consulting

Healthcare Competitive Intelligence Services

Healthcare Asset Prioritization Services

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.  

Contact Us

Sandeep Joshi 

info@delveinsight.com 

+1(919)321-6187 

www.delveinsight.com

Sign up and submit a press release

Sponsored
Venture builder BHV Partners launches Conus Airway to improve anaesthesia  and respiratory surgery

Venture builder BHV Partners launches Conus Airway to improve anaesthesia and respiratory surgery

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

interviews & reviews
Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email